BioCentury | Jun 4, 2019
Financial News

June 4 Financial Quick Takes: Lung Therapeutics' $36M series C; plus Strand, Hansoh, Inhibrx and more

...raised $4.1 million in the first tranche of its series A round, with participation from SDL Ventures...
BioCentury | Sep 6, 2016
Company News

Allergan buys gene therapy play RetroSense

...$12 million in two venture rounds. The company's investors include Nerveda LLC, Blue Water Angels, SDL Ventures...
BioCentury | Jan 12, 2015
Financial News

RetroSense Therapeutics completes venture financing

...Date completed: 2015-01-08 Type: Venture financing Raised: $6 million Investors: Nerveda LLC; Blue Water Angels; SDL Ventures...
Items per page:
1 - 3 of 3
BioCentury | Jun 4, 2019
Financial News

June 4 Financial Quick Takes: Lung Therapeutics' $36M series C; plus Strand, Hansoh, Inhibrx and more

...raised $4.1 million in the first tranche of its series A round, with participation from SDL Ventures...
BioCentury | Sep 6, 2016
Company News

Allergan buys gene therapy play RetroSense

...$12 million in two venture rounds. The company's investors include Nerveda LLC, Blue Water Angels, SDL Ventures...
BioCentury | Jan 12, 2015
Financial News

RetroSense Therapeutics completes venture financing

...Date completed: 2015-01-08 Type: Venture financing Raised: $6 million Investors: Nerveda LLC; Blue Water Angels; SDL Ventures...
Items per page:
1 - 3 of 3